A prominent biomedical ethics expert says that in 20 to 40 years, many prospective parents may choose from dozens of embryos to become their babies and would be provided with genetic information about each embryo to help make the choice. (April 18)
KKR is reportedly close to announcing a deal to buy Envision Healthcare as the private equity firm continues its health-care acquisition spree.
The KKR deal for Envision is expected to be publicized Monday, the Wall Street Journal reported Sunday.
The move would come after Envision announced in October that it would consider “strategic alternatives” for its future, which is business terminology for a possible sale or other restructuring moves.
Envision provides doctor-led medical services at its 261 surgery centers and one surgical hospital in 35 states.
KKR and Envision representatives were not immediately available to comment Sunday afternoon.
KKR has done several health care deals recently, including 2017’s acquisition of WebMD, an online provider of medical information.
The company also recently acquired pharmacy services provider PharMerica Corporation in an investment alongside drug store giant Walgreens Boots Alliance.
The investment firm also announced in November that it had raised $1.45 billion for health care investments.
Follow USA TODAY reporter Nathan Bomey on Twitter @NathanBomey.
Read or Share this story: https://usat.ly/2sWeS6V